Acepodia
Latest round
- Series D
Last raised
- Jun 2023
Total raised
- $256M
Investors
- 8
About Acepodia
Based in California, US, and founded in 2016 by CEO Dr. Sonny Hsiao and co-founder Dr. Patrick Y. Yang, Acepodia Inc. operates as a biotechnology company that develops allogeneic cell therapies for the treatment of cancer. The company also has an office in Taiwan. In June 2023, Acepodia Inc. Acepodia Inc. develops allogeneic cell therapies with Antibody-Cell Conjugation (ACC) platform technology to address gaps in cancer care. The company links tumor-targeting antibodies to its proprietary immune cells, such as gamma delta T cells and off-the-shelf natural killer (NK) cells, to create novel antibody cell effector (ACE) therapies. Acepodia Inc.
Who invested in Acepodia
8 investors across 3 rounds
See all investors in Acepodia
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Acepodia
Who invested in Acepodia?
Acepodia has 8 investors on record across 3 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Acepodia raised?
Acepodia has raised 3 venture rounds. Sign up free to see how much each round raised and the total.
When did Acepodia last raise money?
Acepodia's most recent round on record is a Series D, in Jun 2023.
What does Acepodia do?
Based in California, US, and founded in 2016 by CEO Dr.
Where is Acepodia headquartered?
Acepodia is headquartered in Alameda, US.
Which VCs invest in companies like Acepodia?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back biotechnology companies at Acepodia's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series D
Raising like Acepodia? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.